J&J says DoJ seeking information related to eye products in civil investigation
(Reuters) -Johnson & Johnson disclosed on Friday that the U.S. Department of Justice (DOJ) in July had sought documents and
2023-10-28 05:49
US shifting COVID antivirals to commercial market on Nov. 1
By Ahmed Aboulenein WASHINGTON Most people will retain access to Pfizer's Paxlovid and Merck's Lagevrio COVID-19 oral antiviral
2023-10-28 04:29
David Fincher reveals why he’s glad his ‘World War Z’ sequel never got made: ‘It was a little like The Last of Us’
Years after he was due to make a follow up to Marc Foster’s hit 2013 zombie movie, ‘Fight Club’ filmmaker David Fincher has revealed he is glad his ‘World War Z’ sequel never got off the ground as he thought it was too close to the plot of ‘The Last of Us’.
2023-10-26 18:17
Google, Nvidia Back AI Startup That Helps Combat Chip Shortage
Nvidia Corp. and a Google venture fund have joined a seed round of funding for a startup that
2023-10-26 13:24
Thermo Fisher cuts annual profit forecast on weak biotech demand
(Reuters) -Medical equipment maker Thermo Fisher Scientific on Wednesday cut its annual profit forecast for the second straight quarter, hurt
2023-10-25 18:46
Instagram linked to depression, anxiety, insomnia in kids - US states' lawsuit
Dozens of U.S. states are suing Meta Platforms and its Instagram unit, accusing them of contributing to a
2023-10-25 00:46
EU Aims to Boost Its Wind Industry to Counter China’s Clean Tech Ambitions
The European Union launched a wind power package on Tuesday to counter the growing influence of China and
2023-10-24 20:29
Factbox-Corporate America weighs risks of the Ozempic effect
U.S. companies across sectors such as food and beverage makers and manufacturers of glucose monitors have faced investor
2023-10-20 10:58
Merck signs $5.5 billion deal with Daiichi for cancer therapy development
TOKYO (Reuters) -Japan's Daiichi Sankyo announced on Friday a $5.5 billion agreement with Merck to jointly develop its three precision
2023-10-20 09:23
Carl Icahn sues Illumina board for violating 'fiduciary duties'
(Reuters) -Activist-investor Carl Icahn sued the board of directors at genetic testing company Illumina and accused them of breaching their
2023-10-18 23:45
J&J lifts profit outlook on strong demand for top-seller Stelara
(Reuters) -Johnson & Johnson on Tuesday raised its 2023 profit forecast, helped by resilient demand for its blockbuster anti-inflammatory drug
2023-10-17 19:23
Drug retailer Rite Aid files for bankruptcy, gets $3.45 billion commitment
Rite Aid filed for Chapter 11 bankruptcy on Sunday, a move that would halt lawsuits the drugstore chain
2023-10-16 12:58